Back to results
US 12,319,954 B2Granted
Morphinan compounds
AssigneeConcert Pharmaceuticals, Inc.
InventorRoger Tung
Life of this patent
Estimating the term…
Abstract
This disclosure relates to novel morphinan compounds and their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a σ1 receptor agonist that also has NMDA antagonist activity.
Claims17
A compound having the formula:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.